 |
 |

Malaria Chemoprophylaxis for Coalition Troops in Afghanistan—Reply
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
In Reply: Dr Tepper and colleagues point out that Canadian troops serving in Afghanistan are now offered alternatives to mefloquine for their malaria chemoprophylaxis in theater. Mefloquine has been associated with serious psychiatric events during travel abroad.1 A recent survey of case reports found that mefloquine has also been associated with 19 deaths in users, including 3 suicides.2 It is therefore reasonable to avoid prescribing a drug with potential serious risks (mefloquine) as first-line prophylaxis against an infection (P vivax malaria) that has low regional endemicity, seasonal transmission, and low lethality.
Space limitations in our article precluded addressing the question of terminal prophylaxis with primaquine, an 8-aminoquinoline that is selectively toxic to the pre-erythrocytic stages (tissue schizonts) of plasmodia in the liver and also kills the hypnozoites of P vivax and Plasmodium ovale.3 Blood schizonticides such as chloroquine and mefloquine will not prevent P vivax and P ovale . . . [Full Text of this Article]
Ashley M. Croft, MD
ashley.croft810@land.mod.uk Headquarters Fifth Division Shrewsbury, United Kingdom
Alicia H. Darbyshire, MD
Headquarters International Security Assistance Force Kabul, Afghanistan
Christopher J. Jackson, MD
Camp Souter Kabul, Afghanistan
Pieter P. van Thiel, MD
Academic Medical Center University of Amsterdam Amsterdam, the Netherlands
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED LETTER
Malaria Chemoprophylaxis for Coalition Troops in Afghanistan
Martin Tepper, Steve Schofield, and James Anderson
JAMA. 2007;298(11):1275.
EXTRACT
| FULL TEXT
RELATED ARTICLE
An Outbreak of Malaria in US Army Rangers Returning From Afghanistan
Russ S. Kotwal, Robert B. Wenzel, Raymond A. Sterling, William D. Porter, Nikki N. Jordan, and Bruno P. Petruccelli
JAMA. 2005;293(2):212-216.
ABSTRACT
| FULL TEXT
|